Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after all.
Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Pozzuoli (NA), Italy.
Vincenzo
V
Di Marzo
D000581:Amidohydrolases / Q000037:antagonists & inhibitors*; D000700:Analgesics / Q000627:therapeutic use*; D018771:Arthralgia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007719:Knee Joint; D008297:Male; D011724:Pyridazines / Q000627:therapeutic use*; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000099252:Fatty Acid Amide Hydrolases
D000581:Amidohydrolases; D000700:Analgesics; D011724:Pyridazines; D014508:Urea; D000099252:Fatty Acid Amide Hydrolases; C560620:N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide